跳至主要内容
临床试验/NCT06959017
NCT06959017进行中(未招募)不适用

Is Thromboprotection Preserved in Elderly Ostopenic Patients Who Are Severly Immobilized Before Hip Fracture?

Saglik Bilimleri Universitesi1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
90
试验地点
1
主要终点
HSP 47

研究概览

简要总结

Hip fracture is a common and severe disease in elderly patients. The question of the study is whether elderly patients with severe osteopenia have significantly lower levels of the collagen-binding protein Hsp47 than relatively mobile patients due to advanced immobility before the fracture, and whether they participants have a similar risk of VTE to the normal population despite having had a hip fracture and surgery.

详细描述

In this study, the investigators aimed to prospectively measure the Hsp 47 gene expression levels in patients scheduled for surgery due to intertrochanteric femur fracture and healthy volunteers in the same age group and compare the results with the literature.

Also the complications prior or after surgery will be compared.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •>65 years of age
  • •Interthrocanteric femur fracture AO Type 31A1, 31A2, 31A3
  • •Patients treated proksimal femoral nail
  • •Minor trauma
  • •Fracture mobility score 1,2,3,4,5
  • •Inial thrombocytes count 150.000-450.000 /µL

排除标准

  • •Body mass index >40
  • •Fracture mobility score 6 (unknown type)
  • •stage 4 chronic kidney disease
  • •Patients with rheumatological diseases
  • •Patients at serious risk of VTE(Venous thromboembolism) (according to the International Society on Thrombosis and Hemostasis, categorization of venous thromboembolism) :
  • •Active Hematologic Cancer
  • •Antiphospholipid syndrome
  • •History of recurrent thrombosis (DVT)
  • •Paroxysmal nocturnal hemoglobinuria

研究组 & 干预措施

Sedentary

Active Comparator

This group is consist of the patients with pre-fracture mobility score 3-4-5

干预措施: Gene Expression Analysis (Genetic)

Active

Experimental

This group is consist of the patients with pre-fracture mobility score 1-2

干预措施: Gene Expression Analysis (Genetic)

Control

Experimental

This group is consist of the volunteered healty people which >65 years of age

干预措施: Gene Expression Analysis (Genetic)

结局指标

主要结局

HSP 47

时间窗: Gene expression analysis will be performed once samples are collected from all participants.

HSP 47 (SERPİNH1, ROCK1) gene expression analysis

次要结局

  • Thromboembolie(from fracture occur up to one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

İsmail Demirkale

Prof. Dr. İsmail Demirkale

Saglik Bilimleri Universitesi

研究点 (1)

Loading locations...

相似试验